|
Volumn 21, Issue 6, 2006, Pages 492-500
|
Temporal decline in sirolimus elimination immediately after pancreatic islet transplantation.
a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
CREATININE;
CYP3A5 PROTEIN, HUMAN;
CYTOCHROME P450;
IMMUNOSUPPRESSIVE AGENT;
RAPAMYCIN;
TACROLIMUS;
UNCLASSIFIED DRUG;
ADULT;
ARTICLE;
BIOLOGICAL MODEL;
BLOOD;
BLOOD ANALYSIS;
CLINICAL TRIAL;
FEMALE;
GENETIC POLYMORPHISM;
GENETICS;
GENOTYPE;
GRAFT REJECTION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
LEUKOCYTE COUNT;
LIVER FUNCTION TEST;
MALE;
MASS SPECTROMETRY;
METABOLIC CLEARANCE RATE;
METABOLISM;
METHODOLOGY;
MIDDLE AGED;
PANCREAS ISLET TRANSPLANTATION;
TIME;
ADULT;
ALANINE TRANSAMINASE;
ASPARTATE AMINOTRANSFERASES;
BLOOD CHEMICAL ANALYSIS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
CREATININE;
CYTOCHROME P-450 ENZYME SYSTEM;
DIABETES MELLITUS, TYPE 1;
FEMALE;
GENOTYPE;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
ISLETS OF LANGERHANS TRANSPLANTATION;
LEUKOCYTE COUNT;
LIVER FUNCTION TESTS;
MALE;
MASS SPECTROMETRY;
METABOLIC CLEARANCE RATE;
MIDDLE AGED;
MODELS, BIOLOGICAL;
POLYMORPHISM, GENETIC;
SIROLIMUS;
TACROLIMUS;
TIME FACTORS;
|
EID: 33847758639
PISSN: 13474367
EISSN: None
Source Type: Journal
DOI: 10.2133/dmpk.21.492 Document Type: Article |
Times cited : (9)
|
References (0)
|